膝関節用インプラントの世界市場-2023-2030

市場概要

膝関節インプラントの世界市場規模は、2022年に124億4,000万米ドルに達し、予測期間（2023～2030年）にCAGR4.56%で成長すると予測されています。

膝関節の荷重がかかる面を外科的に置換することで、痛みや障害を緩和します。この手術は、関節リューマチや乾癬性関節炎などの他の膝疾患だけでなく、他の保存療法で関節痛を軽減できない場合に最も頻繁に推奨されています。進行した関節リウマチや外傷、慢性変形性関節症などにより変形が著しい患者さんでは、手術はより困難で危険な場合があります。したがって、人工膝関節置換術を正当化するものではありません。

市場力学

膝関節インプラントの世界市場を牽引する主な要因は、骨に関連する病気や事故の発生率が上昇しており、それが市場の繁栄を牽引していること、二関節保持型人工膝関節全置換術が普及していること、人工膝関節手術の技術向上、新興国での肥満者の増加による膝関節インプラント市場の拡大が予想されること、などです。

骨に関連する病気や事故の発生率が上昇し、市場の隆盛を後押ししています。

米国国立医学図書館によると、患者の骨疾患の最初の外見的兆候となり得る骨折は、骨疾患、特に骨粗鬆症によってもたらされる大きな問題です。毎年、推定150万人が骨の病気による骨折を経験しています。骨折の原因として最も多いのが、骨粗鬆症です。米国では、50歳以上で股関節の骨粗鬆症を患っている人が約1,000万人いると言われています。さらに50歳以上の3360万人は、しばしば「骨減少症」として知られるように股関節の骨量が少なく、骨粗鬆症と将来起こりうる合併症のリスクにさらされています。

また、2021年には、膝関節置換術が米国だけで年間約80万回実施されると予測されるほど、一般的な手術であることが明らかになりました。Personalized Orthopedics of the Palm Beachesによると、この数は年々増加しているそうです。膝関節置換術は、手術や骨の状態が膝関節インプラントの市場を押し上げるため、そのほとんどが外来患者による処置となっています。

WHOは、世界中で毎年130万人が交通事故で死亡し、さらに2,000万人から5,000万人が致命的でない怪我を負っていると推定しています。交通事故による死傷者の半数以上は、歩行者、自転車、オートバイ、およびそれらが運んでいる人が原因です。先に述べたような変数が、膝関節インプラントの需要の上昇につながっているのです。

熟練した外科医の不足と高コストが市場成長の妨げになると予想されます。

整形外科手術の高コストと経験豊富な医師の不足により、市場の改善が必要です。

COVID-19の影響分析

COVID-19の流行により、手術の制限やインプラント手術のキャンセルが広まり、整形外科や医療機器業界は大きな収入減となっています。病院業界は、交差感染の可能性を減らすため、医療スタッフにとって潜在的なリスクとなることが判明する手術の実施回数を制限し、選択的手術を選択しました。交差感染の可能性があるため、パンデミック時にはいくつかの手術が延期を余儀なくされました。膝関節置換術の市場は、パンデミックによって雇用が急速に減少し、人々の可処分所得に大きな影響を与えました。

選択的膝関節置換術のサービスを回復するための大きな障害は、政府が医療行為や選択的手術に対して制限や禁止を設けたことでした。さらに、パンデミックの後、いくつかの病院や外来サービスセンターは、必要なすべての安全措置を講じながら、2020年12月に患者さんへの選択的関節形成術サービスの提供を再開しました。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 骨に関連する病気や事故の発生率は増加しており、市場の繁栄を牽引しています。
    • 人工膝関節手術の技術向上
  • 抑制要因
    • 整形外科手術の高コストと経験豊富な医師の不足により、市場の改善が必要
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• プライシング分析
• 規制分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 タイプ別

• 人工膝関節全置換術
• 人工膝関節部分置換術
• 人工膝関節置換術（リビジョン

第8章 コンポーネントタイプ別

• 固定式人工膝関節（FBI
• 可動式インプラント

第9章 エンドユーザー別

• 病院
• 外来手術センター
• 整形外科クリニック

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク
• 注目の主要企業リスト

第12章 企業プロファイル

• Zimmer Biomet
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Corin Group
• Stryker Corp
• DePuy Synthes
• Smith and Nephew
• Aesculap Implants Systems, LLC
• Exactech, Inc.
• MicroPort Scientific
• CONMED, Kinamed, Inc.
• ConforMIS

第13章 膝関節用インプラントの世界市場-DataM

Market Overview

The global knee implants market size was valued at US$ 12.44 billion in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 4.56% during the forecast period (2023-2030).

The weight-bearing surfaces of the knee joint are replaced surgically to relieve pain and disability; this procedure is most frequently recommended when other conservative measures are ineffective at reducing joint pain, as well as for other knee diseases like rheumatoid arthritis and psoriatic arthritis. Surgery may be more difficult and risky in patients with significant deformities brought on by advanced rheumatoid arthritis, trauma, or chronic osteoarthritis. Hence it is not a justification for knee replacement surgery.

Market Dynamics

The major factors driving the global knee implants market are the incidence of bone-related diseases and accidents is rising, which is driving the market to flourish, bicruciate-retaining total knee arthroplasty is becoming more popular, improvements in technology for knee replacement surgery and the market for knee implants are anticipated to expand as the number of obese people increases in emerging economies.

The incidence of bone-related diseases and accidents is rising, driving the market to flourish.

According to the National Library of Medicine, U.S., fractures, which could be the first outward sign of bone disease in patients, are the major issue brought on by bone disease, particularly osteoporosis. An estimated 1.5 million people experience a fracture due to a bone condition every year. The most common reason for fractures is osteoporosis. In the U.S., there are about 10 million people over 50 who have hip osteoporosis. An additional 33.6 million people over 50 have low hip bone mass, often known as "osteopenia," putting them at risk for osteoporosis and any potential complications in the future.

And the year 2021 reveals that knee replacement surgery is such a common procedure that it is anticipated to be carried out around 800,000 times annually in the United States alone. That number rises yearly, according to Personalized Orthopedics of the Palm Beaches. Most knee replacements are outpatient procedures due to surgeries and bone conditions boosting the market for knee implants.

The WHO estimates that 1.3 million people die in traffic accidents each year around the world, and another 20 to 50 million people get non-fatal injuries. More over half of all fatalities and injuries caused by traffic accidents involve pedestrians, cyclists, motorcyclists, and the people they are carrying. The previously mentioned variables have led to a rise in the demand for knee implants.

Lack of skilled surgeons and high cost are expected to hamper the market's growth.

The market needs to be improved by the high cost of orthopedic surgeries and the scarcity of experienced doctors.

COVID-19 Impact Analysis

The COVID-19 epidemic resulted in significant revenue losses for the orthopaedic and medical device industries due to widespread surgical restrictions and implant procedure cancellations. The hospital industry chose elective operations by limiting the number of procedures performed, which will prove to be a potential risk for the medical staff, to reduce the likelihood of cross-infection. The potential of cross-infection forced several surgeries to be postponed during the pandemic. The market for knee replacement surgery was severely impacted by the pandemic's quick fall in employment, which impacted people's disposable income.

A major obstacle to restoring elective knee arthroplasty services was the government's limitations and bans on medical procedures and elective surgeries. Additionally, after the pandemic, several hospitals and ambulatory service centers resumed providing elective arthroplasty services to patients in December 2020 while taking all necessary safeguards.

Segment Analysis

The total knee replacement segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The total knee replacement segment is the highest market holder in the global knee implants market Due to the increasing demand for implants and the customized replacement systems provided by businesses, Total Knee Replacement (TKR) is dominating. The considerable patient base of people living with arthritis and the rise in the number of patients receiving the operation are further reasons that contribute to the segment's high proportion of the market. Severe osteoarthritis can be effectively treated with total knee arthroplasty (TKA). TKA results in a good recovery from surgery, good survival rates, and general functional improvement. The main surgical objective continues to be to meet the functional expectations of patients having TKA. Consider total knee replacement surgery if nonsurgical options like medication and using walking aids are no longer effective.

The companies are working consistently to deliver cutting-edge, individualized TKR systems centered on certain patients' requirements. For instance, in December 2021, the first surgery in the U.S. to successfully use Pixee Medical, an FDA-cleared augmented reality surgical application for help in total knee arthroplasty, was completed by MicroPort Orthopedics, a world leader in orthopedic equipment and technologies. Through smart glasses and a unique platform called Knee+ from Pixee Medical, orthopedic surgeons may execute operations more effectively and quickly thanks to real-time instrument positioning. Since 90% of surgeons who use a conventional approach and have never used navigation or robotics find Knee+ intuitive, little training is necessary for them to use it.

In November 2022, the reverse hybrid construct for complete knee arthroplasty, the JOURNEY II ROX Total Knee Solution, was unveiled by Smith+Nephew, a leading medical technology provider worldwide. A new procedural product solution has been developed to give surgeons the therapeutic benefit of cutting-edge bearing material and anatomic design along with the effectiveness and potential long-term tibia fixation of a cementless knee.

Geographical Analysis

North America holds the largest market share in the global knee implants market.

North America dominates the global knee implants market primarily due to its large population, excellent medical infrastructure, and high-income levels. Due to the aging population who need knee replacement surgery, North America has grown to be the largest market. This region's rise has largely been attributed to the top market players' presence there. The people's access to high disposable income has made it possible for them to choose cutting-edge medical techniques that incorporate robot assistance and artificial intelligence.

For instance, in September 2021, Zimmer Biomet acquired FDA 510(k) clearance for the ROSA Hip System for robotically-assisted anterior complete hip replacement in order to broaden its ROSA Robotics portfolio, which already includes the ROSA Knee System for total and partial knee replacement. Additionally, the Persona I.Q., supposedly the first and only smart knee approved by the FDA for total knee replacement, was given a De Novo designation by the FDA so that Zimmer Biomet and Canary Medical may market it.

The increase is the result of several reasons, including an increase in accidents and people with degenerative conditions. For instance, according to a report released in June 2021 by the Canadian Institute for Health Information, approximately 75,073 knee replacements were carried out in Canada year 2020. Additionally, it stated that more than 1.4 billion U.S. dollars are spent annually on knee replacement surgeries in Canada.

Competitive Landscape

The Knee Implants market is moderately competitive with local and global companies' presence. Zimmer Biomet, Corin Group, Stryker Corp, DePuy Synthes, Smith and Nephew, Aesculap Implants Systems, LLC, Exactech, Inc., MicroPort Scientific, CONMED, Kinamed, Inc. ConforMIS .and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, inmARCH 2019, the US-based OMNI Orthopedics, a pioneer in robotic-assisted complete knee replacement, has been acquired by UK international orthopedic corporation Corin Group ("Corin"), funded by the Permira funds..

Smith and Nephew.

Overview: The development, production, and marketing of medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT, and advanced wound treatment are the main business activities of Smith & Nephew Plc (Smith & Nephew). The business provides robotics-assisted enabling technologies, trauma products to fix fractures, and knee and hip implants to repair diseased, old, or injured joints.

Product Portfolio:

Genesis II: The GENESIS II Total Knee System has developed into one of the industry's most dependable total knee systems. GENESIS II was built with the most advanced equipment, including the user-friendly MIS system and the ream-through femoral trials, to produce the most complete system..

The global knee implants market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The incidence of bone-related diseases and accidents is rising, driving the market to flourish.
    • 4.1.1.2. Improvements in technology for knee replacement surgery
  • 4.1.2. Restraints:
    • 4.1.2.1. The market needs to be improved by the high cost of orthopedic surgeries and the scarcity of experienced doctors
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1 Porter's Five Forces Analysis
• 5.2 Supply Chain Analysis
• 5.3 Pricing Analysis
• 5.4 Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Total knee replacement
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Partial knee replacement
• 7.4. Revision knee replacement

8. By Component Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
  • 8.1.2. Market Attractiveness Index, By Component Type
• 8.2. Fixed-bearing Implants
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Mobile-bearing Implants

9. By End user

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 9.1.2. Market Attractiveness Index, By End user
• 9.2. Hospitals
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Ambulatory surgical centers
• 9.4. Orthopedic clinics

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size AnalysisUS$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

• 11.1. Key Developments and Strategies
• 11.2. Company Share Analysis
• 11.3. Products Benchmarking
• 11.4. List of Key Companies to Watch

12. Company Profiles

• 12.1. Zimmer Biomet
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Corin Group
• 12.3. Stryker Corp
• 12.4. DePuy Synthes
• 12.5. Smith and Nephew
• 12.6. Aesculap Implants Systems, LLC
• 12.7. Exactech, Inc.
• 12.8. MicroPort Scientific
• 12.9. CONMED, Kinamed, Inc.
• 12.10. ConforMIS

LIST NOT EXHAUSTIVE

13. Global Knee Implants Market - DataM

• 13.1. Appendix
• 13.2. About Us and Application
• 13.3. Contact Us